<i>Plasmodium falciparum</i> Ferredoxin-NADP<sup>+</sup> Reductase-Catalyzed Redox Cycling of Plasmodione Generates Both Predicted Key Drug Metabolites: Implication for Antimalarial Drug Development
نویسندگان
چکیده
Plasmodione (PD) is a potent antimalarial redox-active 3-benzyl-menadione acting at low nanomolar range concentrations on different malaria parasite stages. The specific bioactivation of PD was proposed to occur via cascade redox reactions starting from one-electron reduction and then benzylic oxidation, leading the generation several key metabolites including corresponding alcohol (PD-bzol, for benzhydrol) 3-benzoylmenadione (PDO, oxide). In this study, we showed that oxidation closely related formation semiquinone radical, which can be produced under two conditions: UV photoirradiation or catalysis by Plasmodium falciparum apicoplast ferredoxin–NADP+ reductase (PfFNR) cycling in presence oxygen parent PD. Electrochemical properties both were investigated DMSO water. single-electron potential values PD, PD-bzol, PDO, series 3-benzoylmenadiones determined according ascorbate kinetics. These compounds possess enhanced reactivity toward PfFNR as compared with model quinones. Optimal conditions set up obtain best conversion metabolites. irradiation isopropanol positive pressure led an isolated yield 31% PDO through transient species formed reactions. PfFNR, PD-bzol could observed during long lasting continuously fueled NADPH regenerated enzymatic system. Finally, quantified effect production oxidative stress transgenic 3D7[Api-roGFP2-hGrx1] P. parasites using described genetically encoded glutathione sensor hGrx1-roGFP2 methodology. fast reactive (ROS) pulse released mediated catalyzed PfFNR.
منابع مشابه
Redox proteomics and drug development.
As alterations of the redox homeostasis lie at the root of many pathophysiological processes in human health, redox proteomics holds the promise to shed further light on fundamental biological processes. In this review, the mechanisms of reactive oxygen species (ROS) and reactive nitrogen species (RNS) production are reviewed, mainly addressing those chemical phenomena which have already been a...
متن کاملMedicines for Malaria Venture: sustaining antimalarial drug development.
The Medicines for Malaria Venture (MMV) is committed to discovering, developing and delivering new drugs for malaria. Founded in 1999 as a nonprofit organization bringing private sector management methods to bear on a global public health problem, MMV is today recognized as a leader among the public-private partnerships working on diseases for the developing world. Together with its many partne...
متن کاملAntimalarial drug resistance
Antimalarial drug resistance is of great concern in the WHO South-East Asia (SEA) Region. A high degree of resistance of Plasmodium falciparum to chloroquine and sulfadoxine-pyrimethamine is prevalent in this Region. Multidrug resistance is prevalent in some parts of the Greater Mekong Sub-region. Artemisinin and its derivatives in combination with other effective partner drugs, which showed fa...
متن کاملAntimalarial drug resistance.
Malaria, the most prevalent and most pernicious parasitic disease of humans, is estimated to kill between one and two million people, mainly children, each year. Resistance has emerged to all classes of antimalarial drugs except the artemisinins and is responsible for a recent increase in malaria-related mortality, particularly in Africa. The de novo emergence of resistance can be prevented by ...
متن کاملAntimalarial Drug Toxicity
26 1. Method and Search Strategy 28 2. Chloroquine 29 2.1 Mild and Moderate Adverse Effects 29 2.2 Severe Adverse Effects 30 2.3 Overdose Toxicity 30 2.4 Use in Pregnant Women 31 2.5 Use in Breast-Feeding Women 31 2.6 Contraindications and Cautions 31 3. Suifadoxine/Pyrimethamine 31 3.1 Miid and Moderate Adverse Effects 32 3.2 Severe Adverse Effects 32 3.2.1 Cutaneous Toxicity 32 3.2.2 Hepatic ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: ACS Infectious Diseases
سال: 2021
ISSN: ['2373-8227']
DOI: https://doi.org/10.1021/acsinfecdis.1c00054